When to measure lipid profile after stroke?

Area of Science:

• Neurology
• Cardiology
• Clinical Chemistry

Background:

• Acute decreases in total cholesterol (TC) are known in myocardial infarction but inconsistent in prior stroke studies.
• Lipid level timing is crucial for ischemic stroke management due to recent statin trial findings.
• This study investigates optimal lipid measurement timing post-stroke, hypothesizing an acute TC decrease and 12-week return to baseline.

Purpose of the Study:

• To determine the optimal timing for lipid measurements following an acute ischemic stroke.
• To evaluate the dynamic changes in lipid profiles in the 12 weeks after stroke onset.

Main Methods:

• A prospective, observational study involving 50 acute ischemic stroke patients.
• Fasting lipid profiles (TC, LDL, HDL, triglycerides) measured <48 hours, 4 weeks, and 12 weeks post-ictus.
• Patients included statin-naïve individuals, those on statins, and those newly commenced on statins.

Main Results:

• In statin-naïve patients, a significant increase in total cholesterol was observed at the 12-week follow-up.
• Cholesterol levels demonstrated variability in the acute phase and early weeks post-stroke.
• 38 out of 50 patients completed the 12-week follow-up.

Conclusions:

• Cholesterol levels measured during the acute phase of stroke are unreliable indicators of a patient's true lipid status.
• Initiating statin therapy should be guided by lipid measurements taken approximately 12 weeks after the stroke event.
• This timing allows for a more stable and representative assessment of lipid levels for treatment decisions.